(2R)-2-hydroxy-3-(hexadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
|
IUPAC
|
1-16:0-lysoPC
|
MetaCyc
|
1-16:0-lysophosphatidylcholine
|
MetaCyc
|
1-hexadecanoyl-2-lysophosphatidylcholine
|
ChEBI
|
1-hexadecanoyl-sn-glycero-3-phosphocholine
|
LIPID MAPS
|
1-hexadecanoyl-sn-glycero-3-phosphocholine
|
UniProt
|
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine
|
ChEBI
|
1-palmitoyl-2-lysophosphatidylcholine
|
ChEBI
|
1-palmitoyl-GPC
|
ChEBI
|
1-palmitoyl-GPC (16:0)
|
ChEBI
|
1-palmitoyl-phosphatidylcholine
|
LIPID MAPS
|
1-palmitoyl-sn-glycero-3-phosphocholine
|
ChEBI
|
1-palmitoylphosphatidylcholine
|
SUBMITTER
|
16:0 LYSO-PC
|
LIPID MAPS
|
GPC(16:0)
|
ChEBI
|
GPC(16:0/0:0)
|
ChEBI
|
GPCho 16:0/0:0
|
ChEBI
|
GPCho(16:0/0:0)
|
ChEBI
|
LPC 16:0/0:0
|
ChEBI
|
LPC(16:0)
|
HMDB
|
LPC(16:0/0:0)
|
SUBMITTER
|
LyPC(16:0)
|
HMDB
|
LyPC(16:0/0:0)
|
HMDB
|
LysoPC 16:0/0:0
|
ChEBI
|
LysoPC(16:0)
|
HMDB
|
LysoPC(16:0/0:0)
|
HMDB
|
Lysophosphatidylcholine(16:0)
|
HMDB
|
lysophosphatidylcholine(16:0/0:0)
|
ChEBI
|
PC(16:0/0:0)
|
ChEBI
|